Rationale and design of a randomised trial of intravenous iron in patients with heart failure

OBJECTIVES: For patients with a reduced left ventricular ejection fraction (LVEF) heart failure with reduced ejection fraction (HFrEF) and iron deficiency, administration of intravenous iron improves symptoms, exercise capacity and may in the following 12 months, reduce hospitalisations for heart fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Paul R, Cleland, John GF, Petrie, Mark C, Ahmed, Fozia Z, Foley, Paul WX, Kalra, Philip A, Lang, Ninian N, Lane, Rebecca E, Macdougall, Iain C, Pellicori, Pierpaolo, Pope, Michael T B, Robertson, Michele, Squire, Iain B, Thomson, Elizabeth A, Ford, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Heart Failure and Cardiomyopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726969/
https://www.ncbi.nlm.nih.gov/pubmed/35948408
http://dx.doi.org/10.1136/heartjnl-2022-321304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726969/
https://www.ncbi.nlm.nih.gov/pubmed/35948408
http://dx.doi.org/10.1136/heartjnl-2022-321304

Ejemplares similares